Title: IL‐10 served as an indicator in severe COVID‐19 patients
Abstract: Journal of Medical VirologyVolume 93, Issue 3 p. 1233-1235 LETTER TO THE EDITOR IL-10 served as an indicator in severe COVID-19 patients Fei Huang MM, Fei Huang MM orcid.org/0000-0001-6954-3036 Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China Department of Nephrology and Rheumatology, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaSearch for more papers by this authorXu Liu MD, Xu Liu MD Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXiaolin Sun PhD, Xiaolin Sun PhD Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorZhanguo Li MD, PhD, Corresponding Author Zhanguo Li MD, PhD [email protected] orcid.org/0000-0002-2590-6242 Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China Correspondence Zhanguo Li, MD, PhD, Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South St, 100044 Beijing, China. Email: [email protected]Search for more papers by this author Fei Huang MM, Fei Huang MM orcid.org/0000-0001-6954-3036 Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China Department of Nephrology and Rheumatology, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaSearch for more papers by this authorXu Liu MD, Xu Liu MD Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorXiaolin Sun PhD, Xiaolin Sun PhD Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorZhanguo Li MD, PhD, Corresponding Author Zhanguo Li MD, PhD [email protected] orcid.org/0000-0002-2590-6242 Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China Correspondence Zhanguo Li, MD, PhD, Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South St, 100044 Beijing, China. Email: [email protected]Search for more papers by this author First published: 06 October 2020 https://doi.org/10.1002/jmv.26580Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15): 762–768. https://doi.org/10.1093/cid/ciaa248 10.1093/cid/ciaa248 CASPubMedWeb of Science®Google Scholar 2Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020; 55:102763. https://doi.org/10.1016/j.ebiom.2020.102763 10.1016/j.ebiom.2020.102763 PubMedWeb of Science®Google Scholar 3Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5): 2620–2629. https://doi.org/10.1172/JCI137244 10.1172/JCI137244 CASPubMedWeb of Science®Google Scholar 4Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7): 1–11. https://doi.org/10.1001/jamainternmed.2020.0994 10.1001/jamainternmed.2020.0994 Web of Science®Google Scholar 5Xu B, Fan C, Wang A, et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020; 81(1): e51–e60. https://doi.org/10.1016/j.jinf.2020.04.012 10.1016/j.jinf.2020.04.012 CASPubMedWeb of Science®Google Scholar 6Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020; 71(15): 769–777. https://doi.org/10.1093/cid/ciaa272 10.1093/cid/ciaa272 CASPubMedWeb of Science®Google Scholar 7Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020; 80(6): 639–645. https://doi.org/10.1016/j.jinf.2020.03.019 10.1016/j.jinf.2020.03.019 CASPubMedWeb of Science®Google Scholar 8He R, Lu Z, Zhang L, et al. The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol. 2020; 127:104361. https://doi.org/10.1016/j.jcv.2020.104361 10.1016/j.jcv.2020.104361 CASPubMedWeb of Science®Google Scholar 9Liu Y, Liao W, Wan L, Xiang T, Zhang W. Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19. Viral Immunol. 2020. https://doi.org/10.1089/vim.2020.0062 10.1089/vim.2020.0062 Web of Science®Google Scholar 10Wan S, Yi Q, Fan S, et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol. 2020; 189(3): 428–437. https://doi.org/10.1111/bjh.16659 10.1111/bjh.16659 CASPubMedWeb of Science®Google Scholar 11Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368:m1091. https://doi.org/10.1136/bmj.m1091 10.1136/bmj.m1091 PubMedGoogle Scholar 12Wei YY, Wang RR, Zhang DW, et al. Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China. J Infect. 2020; 81(1): e89–e92. https://doi.org/10.1016/j.jinf.2020.04.010 10.1016/j.jinf.2020.04.010 CASPubMedWeb of Science®Google Scholar 13Yang P, Wang P, Song Y, Zhang A, Yuan G, Cui Y. A retrospective study on the epidemiological characteristics and establishment of an early warning system of severe COVID-19 patients. J Med Virol. 2020; 92: 2173–2180. https://doi.org/10.1002/jmv.26022 10.1002/jmv.26022 CASPubMedWeb of Science®Google Scholar 14Chen R, Sang L, Jiang M, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020; 146(1): 89–100. https://doi.org/10.1016/j.jaci.2020.05.003 10.1016/j.jaci.2020.05.003 CASPubMedWeb of Science®Google Scholar 15Zeng YL, Zhang C, Gao F, et al. Analysis of clinical characteristics of 49 cases of COVID-19. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(8): 654–658. https://doi.org/10.3760/cma.j.cn112147-20200225-00184 CASPubMedGoogle Scholar 16Liu F, Ji C, Luo J, et al. Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019. Sci Rep. 2020; 10(1):13689. https://doi.org/10.1038/s41598-020-70387-2 10.1038/s41598-020-70387-2 CASPubMedWeb of Science®Google Scholar 17Gan J, Li J, Li S, Yang C. Leucocyte subsets effectively predict the clinical outcome of patients with COVID-19 pneumonia: a retrospective case-control study. Front Public Health. 2020; 8: 299. https://doi.org/10.3389/fpubh.2020.00299 10.3389/fpubh.2020.00299 PubMedWeb of Science®Google Scholar 18Li S, Jiang L, Li X, et al. Clinical and pathological investigation of patients with severe COVID-19. JCI Insight. 2020; 5(12):e138070. https://doi.org/10.1172/jci.insight.138070 10.1172/jci.insight.138070 PubMedWeb of Science®Google Scholar 19He S, Zhou C, Lu D, et al. Relationship between chest CT manifestations and immune response in COVID-19 patients. Int J Infect Dis. 2020; 98: 125–129. https://doi.org/10.1016/j.ijid.2020.06.059 10.1016/j.ijid.2020.06.059 CASPubMedWeb of Science®Google Scholar 20Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14: 135. https://doi.org/10.1186/1471-2288-14-135 10.1186/1471-2288-14-135 PubMedWeb of Science®Google Scholar 21Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017; 39(5): 517–528. https://doi.org/10.1007/s00281-017-0639-8 10.1007/s00281-017-0639-8 CASPubMedWeb of Science®Google Scholar Citing Literature Volume93, Issue3Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐XMarch 2021Pages 1233-1235 ReferencesRelatedInformation